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INTRODUCTION: Gingiva fibromatosis is a relatively rare condition characterized by diffuse enlargement of the
gingiva, which is caused by expansion and accumulation of the connective tissue.
OBJECTIVE: The aim of the present study was to investigate proliferative and apoptotic biomarker expression in
normal gingiva and two forms of gingival fibromatosis.
METHODS: Archived tissue specimens of hereditary gingival fibromatosis, gingival fibromatosis and dental
abnormality syndrome and normal gingiva were subject to morphological analysis and immunohistochemical
staining. The results were analyzed statistically.
RESULTS: Proteins associated with proliferation were found in the nuclei of epithelial cells from the basal and
suprabasal layers, whereas apoptotic proteins were detected in the cytoplasm of the upper layers of the epithelium.
Increased expressions of minichromosome maintenance proteins 2 and 5 were observed in the gingival fibromatosis
and dental abnormality syndrome samples. In contrast, geminin expression was higher in normal gingiva samples.
No difference in the expression of apoptotic proteins was observed among the groups.
CONCLUSION: Our findings support a role for augmented proliferation of epithelial cells within the overgrown
tissues associated with gingival fibromatosis or dental abnormality syndrome. However, our data suggest that
different biological mechanisms may account for the pathogenesis of different types of gingival fibromatosis.
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INTRODUCTION
Gingival fibromatosis (GF) is an oral condition clinically
manifested by a generalized and fibrotic enlargement of the
gingiva. It may be induced as a side-effect of systemic
drugs, or it may be inherited.1,2 As an inherited disorder, GF
may be isolated and referred to as hereditary gingival
fibromatosis (HGF), or it may be part of a genetic
syndrome.3 The GF feature has been described as a
syndrome associated with hyperthricosis and/or mental
retardation syndrome, Zimmermann-Laband syndrome,
Murray-Puretic-Drescher syndrome (juvenile hyaline fibro-
matosis), Rutherfurd syndrome, GF with distinctive facies
syndrome, Ramon syndrome, Cross syndrome, Jones
syndrome, and prune belly syndrome.2,4 Recently, GF in
association with dental abnormalities (DA) was reported. In
this case, thin generalized hypoplastic amelogenesis imper-
fecta was indicated as the main dental feature.4
The minichromosome maintenance (Mcm) protein family
is essential for the initiation and elongation of DNA
replication and is comprised of six members (Mcm-2 to
Mcm-7), which are highly conserved in all eukaryotes.5
Mcm proteins have been demonstrated to move quickly
from the cytoplasm into the nucleus as mitosis is completed
where they persist until the next round of division is
initiated.6 Therefore, Mcm proteins have been considered a
novel class of proliferation markers, and their expression
has been used in the prognosis of different disorders.7,8
Geminin is a negative regulator of DNA replication that acts
as a cell proliferation inhibitor.9 As geminin is only
expressed in the S and M phases of the cell cycle, it has
been proposed that geminin could also be a novel
proliferation marker.10 The balance between cell division
and cell death is essential for an organism. Apoptosis is a
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highly regulated form of cell death and is defined by distinct
morphological and biochemical features.11 Abnormal apop-
tosis has been implicated in various diseases, including
cancer, AIDS, periodontal diseases and gingival over-
growth.11-15 Apoptosis is regulated by an interplay of gene
products that can either act as inducers or inhibitors of the
process. Following the discovery of the Bcl-2 gene,16 several
mammalian and viral homologs have been identified. The
Bcl-2 family consists of anti-apoptotic genes, such as Bcl-2,
and pro-apoptotic genes, including Bax.15
The aim of this study was to determine the expression of
proliferative (Mcm-2, Mcm-5 and geminin) and apoptotic
(Bcl-2 and Bax) proteins in samples from two distinct
families affected by an isolated form of GF and one family
affected by GF and DA syndrome.
MATERIALS AND METHODS
Tissue samples. This cross-sectional study included
gingival samples from members of two families with HGF
and one family with GF and DA syndrome. Clinical,
histological and genetic data from these three families
were previously reported. Six tissue samples were selected
from the first HGF family17 (designated GF Family 1 for the
purposes of this study). Four tissue samples were used from
the second HGF family18 (designated GF Family 2). Four
samples were also used from the family affected by GF and
DA syndrome4 (designated GF Family 3). Ten samples of
normal gingiva (NG) were used as controls. New sections
from paraffin-embedded blocks were stained with hema-
toxylin and eosin (H&E) or used for immunohistochemical
analysis. This study was carried out in accordance with the
World Medical Association Declaration of Helsinki and
with approval of the Human Research Ethics Committee of
the University. All of the patients gave consent for this
study.
Immunohistochemical analysis. Immunohistochemistry
was performed using the streptavidin-biotin method.
Briefly, after de-waxing and hydration in graded alcohol
solutions, sections were treated with 3% H2O2, followed by
incubation with 10 mM citric acid pH 6.0 in an electric
pressure cooker to allow for antigen retrieval. After washing
with phosphate-buffered saline (PBS), sections were
incubated with primary antibodies (anti-human Mcm-2
and -5, diluted 1:20, Novocastra; anti-human geminin,
diluted 1:40, Novocastra, Newcastle Upton, Tyne, UK;
anti-human Bax and Bcl-2, diluted 1:50, Dako Corp.,
Carpenteria, CA, USA). Following incubation with Mcm-2,
Mcm-5 or geminin antibody, slides were washed in PBS and
incubated with the secondary antibody (StreptABComplex/
HRP, Dako Corp., Carpenteria, CA, USA, diluted 1:20) for
30 min at 37 C˚. Slides were then incubated with the
streptavidin-biotin complex (StreptABComplex/HRP, Dako,
diluted 1:300) for 30 min. Sections incubated with antibodies
against Bcl-2 and Bax were incubated with the LSAB system
(Labeled Streptavidin Biotin, Dako, diluted 1:100) for 30 min
at 37 C˚. Reactions were developed by incubating the sections
with 0.6 mg/ml 3,39-diaminobenzidine tetrahydrochloride
(Sigma, St. Louis, MO, USA) containing 0.01%H2O2. Negative
and positive controls were performed for each antibody. For
immunohistochemical assessment, the method previously
described by Kantarci et al.14 was used. The orientation of
each sample and the identification of tissue sites were
determined at 100x and 400x magnification. Five sites were
defined and used to determine the labeling index (LI), which
is expressed as the percentage of positive cells at 1000x
magnification with the aid of the image computer analyzer
(Nikon NIS-Elements-2.35, Nikon Corporation, Melville,
USA) for quantification. The sites were chosen to represent
basal and suprabasal cell layers of the epithelium. The
absence of staining was considered negative.
Statistical analysis. Data are presented as the mean¡ SD
for each group. The Kruskal-Wallis multiple comparison test
was used to test group effects, and Spearman’s correlation
test was performed to determine the correlations between
immunohistochemical markers. In our comparisons, p,0.05
was considered indicative of statistical significance.
RESULTS
Histological examination of gingival overgrowth tissues
from both GF Families 1 and 2 stained with H&E revealed
very similar findings. The gingival tissues included a well-
structured epithelium with elongated and thin papillae
inserted into deep fibrous connective tissue with collagen
fiber bundles running in all directions (Fig. 1A-1C). In GF
Family 3, a large number of cementicles and odontogenic
epithelium rests were observed in the connective tissue
Figure 1 - Histological features of the different GF forms in this
study. Shown here are representative samples of GF Family 1 (A),
GF Family 2 (B), and GF Family 3 (C-E). GF samples revealed a well-
structured epithelium with elongated and thin papillae inserted
into deep fibrous connective tissue with collagen fiber bundles
running in all directions. Additionally, GF tissues from Family 3
demonstrated calcifications and odontogenic epithelial rests in
the dense fibrous connective tissue (D and E) (original magnifica-
tion 100x).
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in addition to the previously mentioned features (Fig. 1D
and 1E).
Nuclear immunoreactivity for Mcm-2, Mcm-5 and gemi-
nin was identified in the basal and suprabasal cell layers of
the epithelium, whereas immunoreactivity for Bcl-2 and Bax
was detected in the cytoplasm of the upper layers of the
epithelium (Fig. 2). The staining pattern of the apoptotic
markers was fine and granular with reactivity scattered
throughout the cytoplasm. Some inflammatory cells demon-
strated immunoreactivity for Bcl-2. Normal mesenchymal
cells were not stained by any of the antibodies tested. Both
Mcm-2 and Mcm-5 LIs were significantly higher in GF
Family 3 as compared with NG or GF Family 1, whereas the
LI of geminin was significantly higher in NG as compared
with GF Family 2. A strong and positive correlation between
the LIs of Mcm-2 and Mcm-5 was found (rs = 0.54; p = 0.006).
No statistical differences for Bcl-2 or Bax LIs were observed
in this study. Table 1 summarizes the immunohistochemical
results obtained in the present study.
DISCUSSION
The exact causal mechanism resulting in the accumulation
of excessive gingival tissue in GF remains unclear, and
inquiries of GF pathogenesis have largely focused on the
connective tissue alterations. It has been proposed that GF
develops through activation or selection of the resident tissue
fibroblasts, which is phenotypically characterized by
increased proliferation, low levels of extracellular matrix-
degrading metalloproteinases (MMP-1 and MMP-2) and
abnormally high collagen production.19,20 Histologically, it
has been determined that GF gingiva demonstrates epithelial
alterations such as higher and deeper epithelial papillae.
Previous studies have demonstrated that GF tissues have a
significantly higher number of Ki-67-positive cells as com-
pared with NG epithelia,18 and the expression of epidermal
growth factor (EGF) and its receptor (EGFr) is positively
correlated with the proliferative potential of the cells in the
papilla tip area.21 Data from the present study revealed that
all gingival samples were positive for Mcm-2, Mcm-5 and
geminin expression in the epithelial tissue, although sig-
nificant differences in their expression levels were observed.
A positive correlation between Mcm-2 and Mcm-5 immuno-
histochemical expression was observed, and both markers
were more highly expressed in samples from GF Family 3 as
compared with samples from either the NG group or the GF
Family 1 group. The anti-geminin antibody reacted with a
lower percentage of epithelial cells, although its levels were
significantly higher in the NG group as compared with the
GF Family 2 group. Additionally, Mcm-2 exhibited higher
levels of expression than Mcm-5 and geminin. Finally, no
differences in the levels of apoptotic markers Bcl-2 and Bax
were observed among the groups.
Although an increase in the expression of proliferation
markers in gingival overgrowth may be expected when
compared with NG samples, we did not observe this result
in all groups. Likewise, one might expect fewer apoptotic
cells to be present in proliferating tissues. Nonetheless, these
results may be explained by the intense clinical, genetic and
biological heterogeneity of GFs. Previous studies have
demonstrated that differences often occur in these diseases.
For instance, although the disease manifested as an isolated
finding in both GF Families 1 and 2, it was more severe and
frequently associated with both aesthetic and functional
Figure 2 - Pattern of Mcm-2, Mcm-5 and geminin immunohistochemical staining in NG (top panel; A-C) and GF Family 3 (bottom panel;
D-F) samples. Note that Mcm-2-positive cells (A and D) and Mcm-5-positive cells (B and E) were increased in number in GF Family 3, and
that geminin-positive cells (C and F) were abundant in the NG sample (original magnification 200x).
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problems in GF Family 1. Associated problems included
prominent lips and open lip posture, prolonged retention of
primary dentition due to a delay in the eruption of
permanent teeth, diastemas, malpositioning of the teeth,
and cross or open bites.22 Moreover, disease recurrence was
more frequent in patients from GF Family 1 than it was in
patients from GF Family 2, and the unaffected individuals in
GF Family 2 transmitted the disease to their offspring in an
autosomal dominant pattern despite being clinically unaf-
fected themselves.22 On the other hand, members of GF
Family 3 transmitted the disease in an autosomal recessive
mode of inheritance in association with generalized thin
hypoplastic amelogenesis imperfecta, pulpal calcifications,
root dilacerations, hypodontia, delay of tooth eruption and
pericoronal radiolucencies in unerupted teeth.4 Moreover,
myofibroblasts, the main cell type involved in extracellular
matrix deposition in fibrotic diseases, were found in
abundance in the gingival tissues of patients from GF
Families 2 and 3 but not GF Family 1.22 Another uncommon
finding, which supports the heterogeneity of GF, was that a
broad distribution of calcified psammomatous structures
associated with odontogenic epithelial remnants were
present in the overgrown gingiva in GF Family 3.
Together, these findings suggest that GF is associated with
distinct biological mechanisms, which may be associated
with the genetic defect.
The results presented here also revealed that there were
no apoptotic or proliferating fibroblasts in the connective
tissue of either NG or GF samples. This result is in
agreement with a study by Buduneli et al.,23 which showed
that no Ki-67- or TUNEL-positive fibroblasts were found in
the connective tissue of cyclosporin A (CsA)-induced
gingival overgrowth. However, the authors demonstrated
a significantly lower number of apoptotic keratinocytes in
the CsA group as compared with gingivitis or healthy
control groups, which suggests that decreased apoptosis
may play a prominent role in the pathogenesis of CsA-
induced gingival overgrowth. Handajani et al.24 showed
that nifedipine treatment resulted in the increased expres-
sion of Bcl-2 by gingival keratinocytes in a dose- and time-
dependent manner. Another study suggested that c-Myc
and Bcl-2 may be associated with the pathogenesis of the
gingival overgrowth induced by nifedipine and phenytoin,
particularly with the morphogenesis of the hyperplastic
gingival epithelia that exhibited increased cell mitotic
activity.25 In contrast, Kantarci et al.14 identified both
PCNA-positive and TUNEL-positive fibroblasts in the
connective tissue of phenytoin-, CsA- and nifedipine-
induced gingival overgrowth as well as in GF. These
authors demonstrated that, independently of the gingival
overgrowth tissue, the number of fibroblasts in apoptosis
was significantly reduced as compared with the NG control,
while the proliferative potential of these cells was signifi-
cantly higher than in the control samples. These differences
may have been related to the methodology as both the
PCNA antibody and TUNEL assays are low specificity
methods.
In conclusion, our results confirmed the heterogeneity of
GF and demonstrated that gingival epithelial cells from GF
and DA syndrome have an elevated proliferative potential.
Although no difference in Bcl-2 or Bax expression among
GF and NG groups was observed, future studies are
necessary to determine the exact role of apoptosis in the
various forms of GF and whether it contributes to GF
pathogenesis.
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